FI98461B - Menetelmä terapeuttisesti käyttökelpoisten yhdisteiden valmistamiseksi - Google Patents

Menetelmä terapeuttisesti käyttökelpoisten yhdisteiden valmistamiseksi

Info

Publication number
FI98461B
FI98461B FI911420A FI911420A FI98461B FI 98461 B FI98461 B FI 98461B FI 911420 A FI911420 A FI 911420A FI 911420 A FI911420 A FI 911420A FI 98461 B FI98461 B FI 98461B
Authority
FI
Finland
Prior art keywords
preparation
therapeutically useful
useful compounds
compounds
therapeutically
Prior art date
Application number
FI911420A
Other languages
English (en)
Swedish (sv)
Other versions
FI98461C (fi
FI911420A (fi
FI911420A0 (fi
Inventor
Norton Paul Peet
Nelsen Lowell Lentz
Original Assignee
Merrell Dow Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merrell Dow Pharma filed Critical Merrell Dow Pharma
Publication of FI911420A0 publication Critical patent/FI911420A0/fi
Publication of FI911420A publication Critical patent/FI911420A/fi
Application granted granted Critical
Publication of FI98461B publication Critical patent/FI98461B/fi
Publication of FI98461C publication Critical patent/FI98461C/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
    • C07D473/04—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms
    • C07D473/06—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
FI911420A 1990-03-26 1991-03-25 Menetelmä terapeuttisesti käyttökelpoisten yhdisteiden valmistamiseksi FI98461C (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US07/499,111 US5047534A (en) 1990-03-26 1990-03-26 Selective adenosine receptor agents
US49911190 1990-03-26

Publications (4)

Publication Number Publication Date
FI911420A0 FI911420A0 (fi) 1991-03-25
FI911420A FI911420A (fi) 1991-09-27
FI98461B true FI98461B (fi) 1997-03-14
FI98461C FI98461C (fi) 1997-06-25

Family

ID=23983864

Family Applications (1)

Application Number Title Priority Date Filing Date
FI911420A FI98461C (fi) 1990-03-26 1991-03-25 Menetelmä terapeuttisesti käyttökelpoisten yhdisteiden valmistamiseksi

Country Status (22)

Country Link
US (1) US5047534A (fi)
EP (1) EP0449175B1 (fi)
JP (1) JP3181305B2 (fi)
KR (1) KR100195368B1 (fi)
CN (1) CN1032815C (fi)
AR (1) AR247887A1 (fi)
AT (1) ATE156130T1 (fi)
AU (1) AU632914B2 (fi)
CA (1) CA2038747C (fi)
DE (1) DE69127010T2 (fi)
DK (1) DK0449175T3 (fi)
ES (1) ES2107431T3 (fi)
FI (1) FI98461C (fi)
GR (1) GR3025135T3 (fi)
HU (1) HU208824B (fi)
IE (1) IE910982A1 (fi)
IL (1) IL97656A (fi)
NO (1) NO177591C (fi)
NZ (1) NZ237484A (fi)
PH (1) PH27511A (fi)
PT (1) PT97133B (fi)
ZA (1) ZA912038B (fi)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5208240A (en) * 1991-03-12 1993-05-04 Merrell Dow Pharmaceuticals Inc. 8-substituted purines as selective adenosine receptor agents
JP2928386B2 (ja) * 1992-07-08 1999-08-03 協和醗酵工業株式会社 うつ病治療剤
AU680241B2 (en) * 1993-02-26 1997-07-24 Merrell Pharmaceuticals Inc. Xanthine derivatives as adenosine A1 receptor antagonists
AU6781194A (en) * 1993-05-03 1994-11-21 United States Of America, Represented By The Secretary, Department Of Health And Human Services, The 8-substituted 1,3,7-trialkyl-xanthine derivatives as a2-selective adenosine receptor antagonists
EP0697020A1 (en) * 1993-05-06 1996-02-21 Merrell Pharmaceuticals Inc. 8-substituted xanthines as selective adenosine receptor agents
US5629298A (en) * 1995-03-13 1997-05-13 University Of Massachusetts Medical Center Adenosine as a positive inotrop in the compromised heart
GB9819382D0 (en) * 1998-09-04 1998-10-28 Cerebrus Ltd Chemical compounds I
US6258794B1 (en) 1999-12-14 2001-07-10 The Mclean Hospital Corporation Treatment of mental conditions including depression
EP1631294B1 (en) 2003-06-10 2010-09-15 Kyowa Hakko Kirin Co., Ltd. A method of treating an anxiety disorder
WO2007036491A1 (de) * 2005-09-30 2007-04-05 Basf Aktiengesellschaft Verfahren zur herstellung von alpha-substituierten carbonsäuren
US7592461B2 (en) * 2005-12-21 2009-09-22 Bristol-Myers Squibb Company Indane modulators of glucocorticoid receptor, AP-1, and/or NF-κB activity and use thereof
KR102060903B1 (ko) * 2018-09-12 2019-12-30 김지훈 다중접합 도마 및 그 제조방법

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1435916A (en) * 1972-05-11 1976-05-19 Beecham Group Ltd Pharmaceutical weight-reducing compositions
SE416810C (sv) * 1977-10-14 1982-07-19 Draco Ab Forfarande for framstellning av xantinderivat med antiallergisk aktivitet
JPS57198544A (en) * 1981-05-28 1982-12-06 Sony Corp Manufacture of magnetic recording medium
US4593095A (en) * 1983-02-18 1986-06-03 The Johns Hopkins University Xanthine derivatives
US4772607A (en) * 1986-05-20 1988-09-20 Warner-Lambert Company Dialkenyl derivatives of xanthine, pharmaceutical compositions and methods of use therefor
US4783530A (en) * 1986-11-13 1988-11-08 Marion Laboratories, Inc. 8-arylxanthines
DE3843117A1 (de) * 1988-12-22 1990-06-28 Boehringer Ingelheim Kg Neue xanthinderivate mit adenosin-antagonistischer wirkung

Also Published As

Publication number Publication date
NO911200L (no) 1991-09-27
NZ237484A (en) 1993-10-26
PH27511A (en) 1993-08-18
IL97656A0 (en) 1992-06-21
NO911200D0 (no) 1991-03-25
FI98461C (fi) 1997-06-25
AR247887A1 (es) 1995-04-28
HUT56570A (en) 1991-09-30
PT97133B (pt) 1998-07-31
NO177591C (no) 1995-10-18
JPH04221384A (ja) 1992-08-11
GR3025135T3 (en) 1998-02-27
EP0449175A2 (en) 1991-10-02
IL97656A (en) 1996-06-18
CN1055181A (zh) 1991-10-09
ATE156130T1 (de) 1997-08-15
JP3181305B2 (ja) 2001-07-03
KR910016752A (ko) 1991-11-05
KR100195368B1 (ko) 1999-06-15
ZA912038B (en) 1991-12-24
IE910982A1 (en) 1991-10-09
AU7353791A (en) 1991-10-03
HU208824B (en) 1994-01-28
AU632914B2 (en) 1993-01-14
FI911420A (fi) 1991-09-27
ES2107431T3 (es) 1997-12-01
EP0449175A3 (en) 1993-01-20
CA2038747C (en) 2002-05-28
EP0449175B1 (en) 1997-07-30
DE69127010D1 (de) 1997-09-04
CA2038747A1 (en) 1991-09-27
NO177591B (no) 1995-07-10
FI911420A0 (fi) 1991-03-25
DK0449175T3 (da) 1998-02-23
PT97133A (pt) 1991-12-31
US5047534A (en) 1991-09-10
CN1032815C (zh) 1996-09-18
DE69127010T2 (de) 1997-11-13

Similar Documents

Publication Publication Date Title
FI883064A (fi) Menetelmä terapeuttisesti käyttökelpoisten heterosyklisten yhdisteiden valmistamiseksi
FI92934B (fi) Analogiamenetelmä terapeuttisesti käyttökelpoisten 1-deoksinojirimysiinijohdannaisten valmistamiseksi
NO179448C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive forbindelser
FI90769C (fi) Menetelmä terapeuttisesti käyttökelpoisten triatsoliyhdisteiden valmistamiseksi
FI880941A0 (fi) Menetelmä terapeuttisesti käyttökelpoisten piperatsinyyli-heterosyklisten yhdisteiden valmistamiseksi
FI893809A (fi) Menetelmä terapeuttisesti käyttökelpoisten fungisidisten triatsoliyhdisteiden valmistamiseksi
NO175978C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive bis-aza-bicykliske forbindelser
FI930723A (fi) Menetelmä terapeuttisesti aktiivisten tiatsolidiinijohdannaisten valmistamiseksi
FI93215C (fi) Menetelmä terapeuttisesti käyttökelpoisten aminoalkoksifenyylijohdannaisten valmistamiseksi
FI880467A (fi) Menetelmä terapeuttisesti käyttökelpoisten substituoitujen 3,4-dihydro-2H-bentsopyraanien valmistamiseksi
FI104075B1 (fi) Menetelmä terapeuttisesti käyttökelpoisten 2-karboksitienyylikarbamoyylipyrrolidin-4-yylitiokarbapeneemi-3-karboksyylihappojohdannaisten valmistamiseksi
FI98461B (fi) Menetelmä terapeuttisesti käyttökelpoisten yhdisteiden valmistamiseksi
FI902316A0 (fi) Menetelmä valmistaa terapeuttisesti vaikuttavia substituoituja dihydropyrrolitsiiniyhdisteitä
FI893003A0 (fi) Menetelmä uusien terapeuttisesti käyttökelpoisten neplanosiinijohdannaisten valmistamiseksi
FI911701A (fi) Menetelmä terapeuttisesti käyttökelpoisten 2-substituoitujen alkyyli-3-karboksikarbapeneemien valmistamiseksi
FI903077A0 (fi) Menetelmä valmistaa terapeuttisesti aktiivisia R(-)-3-kinuklidinolijohdannaisia
FI92188C (fi) Menetelmä terapeuttisesti käyttökelpoisten fenoksialkyylipyrokatekolijohdannaisten valmistamiseksi
FI892144A0 (fi) Menetelmä 5-C-hydroksimetyylialdoheksoosipohjaisten yhdisteiden valmistamiseksi
NO178577C (no) Fremgangsmåte til fremstilling av cefalosporin
FI102841B1 (fi) Menetelmä mannitolin valmistamiseksi
FI914874A (fi) Menetelmä uusien terapeuttisesti käyttökelpoisten C-3-ditioasetaalisubstituoitujen karbapeneemiyhdisteiden valmistamiseksi
NO174196C (no) Fremgangsmåte for fremstilling av omega-decenol
FI97885B (fi) Menetelmä terapeuttisesti aktiivisten nojirimysiinijohdannaisten valmistamiseksi
FI901604A0 (fi) Uusien tieno-triatsolo-diatsepiinien valmistusmenetelmä
NO950203D0 (no) Fremgangsmåte for fremstilling av propargylazetidion-forbindelser

Legal Events

Date Code Title Description
BB Publication of examined application